Loading…
Ultralife Corporation is projected to rise to $9.79 by 2027, a +26% move from its current price of $7.75. ULBI is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean strong buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 5/28/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| May 29 | $7.48 | $7.75 | $8.04 | +0.05% |
| May 30 | $7.37 | $7.76 | $8.17 | +0.10% |
| May 31 | $7.29 | $7.76 | $8.27 | +0.15% |
| Jun 1 | $7.22 | $7.77 | $8.35 | +0.20% |
| Jun 2 | $7.16 | $7.77 | $8.43 | +0.25% |
| Jun 3 | $7.11 | $7.77 | $8.50 | +0.30% |
| Jun 4 | $7.06 | $7.78 | $8.57 | +0.35% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $7.06 | $7.78 | $8.57 | +0.35% |
| Week 2 | $6.81 | $7.80 | $8.95 | +0.71% |
| Week 3 | $6.63 | $7.83 | $9.26 | +1.07% |
| Week 4 | $6.48 | $7.86 | $9.53 | +1.42% |
| Week 5 | $6.36 | $7.89 | $9.79 | +1.78% |
| Week 6 | $6.25 | $7.92 | $10.03 | +2.14% |
| Week 7 | $6.15 | $7.94 | $10.25 | +2.50% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Ultralife Corporation designs, manufactures, installs, and maintains power, and communication and electronics systems worldwide. The company operates in two segments, Battery & Energy Products and Communications Systems. The Battery & Energy Products segment offers lithium 9-volt, cylindrical, thin lithium manganese dioxide, rechargeable, and other non-rechargeable batteries; lithium-ion cells, multi-kilowatt module lithium-ion battery systems, and uninterruptable power supplies; and rugged military and commercial battery charging systems and accessories, including smart chargers, multi-bay charging systems, and various cables.
The Communications Systems segment provides communications systems and accessories to support military communications systems, such as radio frequency amplifiers, power supplies and cables, connector assemblies, amplified speakers, equipment mounts, case equipment, man-portable systems, and integrated communication systems for fixed or vehicle applications comprising vehicle amplifier-adaptors, vehicle installed power enhanced rifleman appliqué systems, and SATCOM systems. The company sells its products under the Ultralife, Ultralife HiRate, Ultralife Thin Cell, Lithium Power, McDowell Research, AMTI, ABLE, ACCUTRONICS, ACCUPRO, ENTELLION, SWE Southwest Electronic Energy Group, SWE SEASAFE, Excell Battery Group, Criterion Gauge, and POW-R BMS brands through original equipment manufacturers, and industrial and defense supply distributors. In addition, it sells its 9-volt battery to the broader consumer market through national and regional retail chains and online retailers.
It serves government, defense, and commercial sectors. The company was incorporated in 1990 and is headquartered in Newark, New York.
Ultralife Corporation (ULBI) is currently priced at $7.75 per share, with a market capitalization of $129.09M and a market-rank of 4059. The stock sits within a longer-term forecast that indicates upside potential across multiple years. The 2026 forecast shows an average price of $7.75, with a path toward higher highs by 2030 and a substantial rise by 2050, where the average is $56.56 and the implied upside along the way is reflected in rising ROIs, up to 629.8% by 2050.
The outlook turns bullish from 2027 onward, with consistently higher average prices and strong upside potential through 2035 and beyond.
A major floor 33.9% below — a decisive break under it would weaken the trend.
The nearest floor, 24.1% below — buyers have tended to step in here.
Price is pressing into resistance (2.6% away) — a breakout level to watch.
A major ceiling 19.5% above — clearing it would confirm fresh momentum.
Key ULBI support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of ULBI market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $6.66 | Buy | $6.88 | Buy |
| MA 10 | $6.35 | Buy | $6.61 | Buy |
| MA 20 | $6.47 | Buy | $6.58 | Buy |
| MA 50 | $6.78 | Buy | $6.61 | Buy |
| MA 100 | $6.46 | Buy | $6.53 | Buy |
| MA 200 | $6.44 | Buy | $6.59 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 67.75 | Neutral |
| Stoch RSI (14) | 100.00 | Sell |
| CCI (20) | 199.78 | Buy |
| Williams %R (14) | 0.00 | Info |
| MACD (12,26,9) | 0.13 | Buy |
| ROC (12) | 29.82 | Buy |
| Bollinger %B (20,2) | 1.15 | Sell |
| Stochastic %K (14) | 100.00 | Sell |
| TRIX (15) | -0.38 | Sell |
| Awesome (5,34) | -0.19 | Sell |
| Ultimate (7,14,28) | 79.21 | Sell |
| Momentum (10) | 1.84 | Buy |
| Aroon Osc (25) | -56.00 | Sell |
| Hull MA (9) | 7.08 | Buy |
| ADX (14) | 19.10 | Neutral |
| ATR (14) | 0.25 | Info |
The 30-day technical picture leans bullish, with RSI14 at 70. The stock trades above both the 50-day and 200-day moving averages, which stand at $6.78 and $6.44 respectively, signaling constructive momentum. Near-term support rests at $5.88, while immediate resistance sits at $7.95.
Over the last 30 days, the price has traded in a range from $6.09 to $9.86, framing a constructive but volatile short-term environment.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $5.25 | $7.75 | $11.22 | 0% | Neutral | |
| $7.51 | $9.79 | $13.66 | +26% | Bullish | |
| $8.19 | $11.09 | $16.19 | +43% | Bullish | |
| $8.07 | $11.28 | $17.06 | +46% | Bullish | |
| $8.23 | $11.83 | $18.44 | +53% | Bullish | |
| $8.66 | $12.78 | $20.45 | +65% | Bullish | |
| $10.91 | $16.51 | $27.03 | +113% | Bullish | |
| $13.07 | $20.23 | $33.83 | +161% | Bullish | |
| $13.13 | $20.79 | $35.44 | +168% | Bullish | |
| $13.52 | $21.88 | $37.98 | +182% | Bullish | |
| $20.31 | $36.32 | $67.92 | +369% | Bullish | |
| $26.39 | $56.56 | $117.74 | +630% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| May 2026 | $5.25 | $7.75 | $9.11 | +0.00% |
| June 2026 | $6.50 | $7.69 | $9.35 | -0.80% |
| July 2026 | $6.78 | $8.12 | $10.05 | +5.55% |
| August 2026 | $6.98 | $8.42 | $10.57 | +3.81% |
| September 2026 | $6.81 | $8.28 | $10.51 | -1.71% |
| October 2026 | $6.81 | $8.34 | $10.69 | +0.70% |
| November 2026 | $7.04 | $8.67 | $11.21 | +3.94% |
| December 2026 | $6.95 | $8.61 | $11.22 | -0.65% |
Click any year to see its month-by-month ULBI forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
In 2026, ULBI is projected to trade between $5.25 and $11.22, averaging $7.75 — a potential gain of 0% from today's $7.75. A consolidation phase looks the most probable path here.
Ultralife Corporation's 2027 outlook centres on $9.79, within a $7.51 to $13.66 range. That is up +26% on the projected 2026 average. That marks a +26% change versus current levels. Momentum favours further upside here.
By 2028, ULBI could reach as high as $16.19, with a base case around $11.09 and support toward $8.19 — roughly +43% from $7.75. Buyers look set to stay in control over this stretch.
Expect ULBI to range from $8.07 to $17.06 through 2029. The $11.28 average target implies a +46% move from current prices. That is up +2% on the projected 2028 average. Momentum favours further upside here.
The ULBI price prediction for 2030 points to an average of $11.83 (low $8.23, high $18.44) — a potential gain of +53% on today's $7.75. Buyers look set to stay in control over this stretch.
In 2031, ULBI is projected to trade between $8.66 and $20.45, averaging $12.78 — a potential gain of +65% from today's $7.75. That is up +8% on the projected 2030 average. Momentum favours further upside here.
Ultralife Corporation's 2032 outlook centres on $16.51, within a $10.91 to $27.03 range. That is up +29% on the projected 2031 average. That marks a +113% change versus current levels. Buyers look set to stay in control over this stretch.
By 2033, ULBI could reach as high as $33.83, with a base case around $20.23 and support toward $13.07 — roughly +161% from $7.75. Momentum favours further upside here.
Expect ULBI to range from $13.13 to $35.44 through 2034. The $20.79 average target implies a +168% move from current prices. That is up +3% on the projected 2033 average. Buyers look set to stay in control over this stretch.
The ULBI price prediction for 2035 points to an average of $21.88 (low $13.52, high $37.98) — a potential gain of +182% on today's $7.75. Momentum favours further upside here.
In 2040, ULBI is projected to trade between $20.31 and $67.92, averaging $36.32 — a potential gain of +369% from today's $7.75. That is up +66% on the projected 2035 average. Buyers look set to stay in control over this stretch.
Ultralife Corporation's 2050 outlook centres on $56.56, within a $26.39 to $117.74 range. That is up +56% on the projected 2040 average. That marks a +630% change versus current levels. Momentum favours further upside here.
Investing $1,000 in ULBI today (≈ 129.032258 ULBI) could be worth
$7,297.67
+$6,297.67 (+630%) by 2050 · US Dollar
Based on the average projected ULBI price of $56.56 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in ULBIwould be worth at today's price.
$1,000 invested in ULBI on May 27, 2025 (≈ 163.398696 ULBI) would be worth
$1,266.34
+$266.34 (+26.6%) today · 1.27× · US Dollar
Based on a ULBI entry price of $6.12 vs. today's $7.75.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $5.99 | $1,293.82 | +29.4% |
| 1 month ago | $7.12 | $1,088.48 | +8.8% |
| 3 months ago | $5.8 | $1,336.21 | +33.6% |
| 6 months ago | $5.69 | $1,362.04 | +36.2% |
| 1 year ago | $6.12 | $1,266.34 | +26.6% |
| All time (5.0y) ago | $9.39 | $825.35 | -17.5% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our ULBI forecast.
Our base-case forecast reaches $16.00 around 2032.
Implied market cap at $16.00: $266.51M
From 2027 through 2030 the forecast shows bullish sentiment and rising averages: 2027 avg $9.79 with ROI 26.3%, 2028 avg $11.09 with ROI 43.1%, 2029 avg $11.28 with ROI 45.5%, and 2030 avg $11.83 with ROI 52.7%. These figures reflect a steady improvement in the projected price path and upside potential over the near term.
Tap a question to reveal the answer.
2030 avg $11.83; min $8.23; max $18.44; ROI 52.7%; sentiment BULLISH.
The forecast shows bullish sentiment from 2027 onward with rising averages: 2027 avg $9.79 (ROI 26.3%), 2030 avg $11.83 (ROI 52.7%), 2040 avg $36.32 (ROI 368.6%), and 2050 avg $56.56 (ROI 629.8%). These are estimates, not guarantees.
2033 avg $20.23; min $13.07; max $33.83; ROI 161%; sentiment BULLISH.
Current price $7.75; Market cap $129.09M.
30-day range low $6.09, high $9.86; RSI14 70.
Ultralife Corporation Community Discussion
0Share your Ultralife Corporation price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.